It also needs guidance from an experienced researcher to prevent its side effects
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes | New England Journal of Medicine Key Points: Objective: The aim was to compare the effects of SGLT2 inhibitors versus placebo in patients with recent (within 8 weeks) and previous (more than 8 weeks) MI, with a focus on heart failure (HF) hospitalization, major adverse cardiovascular events (MACE), and all-cause mortality
It can improve sex hormone levels, restore the menstrual cycle, promote primordial follicle development, and increase oocyte retrieval rates, all while improving the reproductive potential of POI patients [386,387,388]
Follow-Ups That Fit: Well see you regularly (in-office or virtual) to monitor progress and adjust the plan
Tie Coverage to Lifestyle Support Programs Drugs alone wont solve obesity